These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19683800)

  • 1. Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics.
    Draga RO; Grimbergen MC; Kok ET; Jonges TN; Bosch JL
    Urology; 2009 Oct; 74(4):851-6. PubMed ID: 19683800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
    Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
    Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
    Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
    J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
    Lipiński MI; Jeromin LM
    Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
    Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
    Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?
    Gravas S; Efstathiou K; Zachos I; Melekos MD; Tzortzis V
    Can J Urol; 2012 Jun; 19(3):6269-73. PubMed ID: 22704312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy.
    Grimbergen MC; van Swol CF; Jonges TG; Boon TA; van Moorselaar RJ
    Eur Urol; 2003 Jul; 44(1):51-6. PubMed ID: 12814675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
    Loidl W; Schmidbauer J; Susani M; Marberger M
    Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
    Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
    J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quality of 5-aminolevulinic acid-induced photodynamic diagnosis and transurethral resection of bladder tumors: does the urologist play a role?
    Draga RO; Grimbergen MC; Kok ET; Jonges TN; van Swol CF; Bosch RJ
    Urol Int; 2012; 89(3):326-31. PubMed ID: 22986952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
    Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
    J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
    Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
    Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
    Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C
    BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
    Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
    J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluorescent diagnostics of urinary bladder cancer].
    Lopatkin NA; Kamalov AA; Kudriavtsev IuV; Tokarev FV
    Urologiia; 2000; (4):3-6. PubMed ID: 11186690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.